Invitae

NYSE NVTA
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 19 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

5.24M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.36B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.83
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

275.60M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-96.97 %

Upcoming events Invitae

All events
No upcoming events scheduled

Stock chart Invitae

Stock analysis Invitae

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

- 48.62
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

0.05 28.13
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-1.03 14.76
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

-1.02 2.03
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

132.97 74.85

Price change Invitae per year

24.16$ 61.59$
Min Max

Summary analysis Invitae

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Invitae

Revenue and net income Invitae

All parameters

Stock news Invitae

All news

SoftBank-Backed Medical Genetics Company Invitae Prepares for Bankruptcy

Invitae Names David Sholehvar Operating Chief in Latest C-Suite Addition

Invitae Names David Sholehvar Operating Chief in Latest C-Suite Addition

FDA Gives Marketing Authorization to Invitae Test for Cancer Genes

FDA Gives Marketing Authorization to Invitae Test for Cancer Genes

Invitae Names Ana Schrank as New CFO

Invitae Names Ana Schrank as New CFO

Invitae Names Robert Dickey as Interim Finance Chief

Invitae Names Robert Dickey as Interim Finance Chief

Invitae Financial Chief Wen to Resign; Gorjanc Named Interim Successor

Invitae Financial Chief Wen to Resign; Gorjanc Named Interim Successor

Invitae Up 26% on High Volume Two Days After Post-Earnings Surge

Invitae Up 26% on High Volume Two Days After Post-Earnings Surge

Invitae Shares Surge After 2Q Results

Invitae Shares Surge After 2Q Results

Invitae Shares Drop 10% on Lower Guidance, Restructuring

Invitae Shares Drop 10% on Lower Guidance, Restructuring

Invitae Realigns Operations to Generate Sustainable Margins, Path to Positive Cash Flow

Invitae Realigns Operations to Generate Sustainable Margins, Path to Positive Cash Flow

Invitae Names Kenneth Knight CEO, Part of Broader Leadership Shuffle

About company Invitae

Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. It has a collaboration with Pacific Biosciences of California, Inc. to develop a production-scale high-throughput HiFi sequencing platform. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Address:
1400 16th Street, San Francisco, CA, United States, 94103
Company name: Invitae
Issuer ticker: NVTA
ISIN: US46185L1035
Country: USA
Exchange: NYSE
Currency: $
IPO date: 2015-02-12
Sector: Healthcare
Industry: Biotechnology
Site: https://www.invitae.com

On which stock exchange are Invitae (NVTA) stocks traded?

Invitae (NVTA) stocks are traded on NYSE.

What is the ticker of Invitae stocks (NVTA)?

The stock ticker of Invitae’s stocks or in other words, the code is NVTA. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Invitae (NVTA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Invitae (NVTA) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Invitae (NVTA) stocks traded?

Invitae (NVTA) stocks are traded on the NYSE exchange in dollars.

What is the price of Invitae (NVTA) stocks today?

The current price of Invitae stocks on 19.05.2024 is dollars. per share.

What is the dynamics of Invitae (NVTA) stocks from the beginning of the year?

Invitae (NVTA) quotes have increased by -100% from the beginning of the year up to dollars. per 1 stocks.

How much did Invitae (NVTA) stocks increase in мае 2024?

This month Invitae (NVTA) quotes have increased by 0% to dollars. per share.

How much are Invitae (NVTA) stocks worth?

Today, on October, 19.05.2024 Invitae’s (NVTA) stocks cost dollars..

What is the market capitalization of Invitae (NVTA)?

Capitalization is the market value of Invitae (NVTA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of Invitae (NVTA) is estimated at about 5236476 dollars.